SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.50    5.50 (1.57%)
Bid:
354.00
Ask:
358.00
Spread: 4.00 (1.13%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Directorate Change

18 Mar 2015 07:00

RNS Number : 6993H
Caledonia Investments PLC
18 March 2015
 



Caledonia Investments plc

 

Announcement of board and committee changes

 

 

The Board of Caledonia Investments plc ("Caledonia" or the "Company") is pleased to announce the following changes to its board and committee membership.

 

David Stewart and Shonaid Jemmett-Page are appointed as independent non-executive directors, David with immediate effect and Shonaid with effect from 1 July 2015.

 

David began his career at Swire Pacific in 1981, working in various roles in Australia, Thailand, the Philippines and Hong Kong. In 1986 he moved into the financial sector, first to James Capel, where he set up and managed research and sales desks in London and Tokyo specialising in Asian derivatives products, and then in 1995 to Fidelity Investments, where he was head of its emerging markets funds and then president of its Institutional UK/EMEA business. In 2005, David joined Odey Asset Management as Chief Executive Officer, a position he held for eight years before moving to a non-executive director role from 2013 to 2014. David is currently Chairman and a co-founder of IMM Associates and a non-executive executive adviser to the board of Knight Frank.

 

David will join Caledonia's Audit, Nomination and Remuneration Committees.

 

Shonaid Jemmett-Page spent the first twenty years of her career at KPMG in London and Tokyo, rising to the position of Partner, Financial Services. In 2001, she moved to Unilever, where she was Senior Vice President, Finance and Information for Asia, based in Singapore, before returning to the UK as Finance Director for Unilever's global non-food business. In 2009, Shonaid joined CDC Group as Chief Operating Officer, a position she held until 2012. Since then, Shonaid has focussed on non-executive appointments and is currently a non-executive director and chair of the audit committee of GKN, APR Energy, Amlin, Origo Partners and Greencoat UK Wind. Within the past five years she has also held non-executive directorships of Havelock Europa and Close Brothers Group.

 

Shonaid will join Caledonia's Governance, Nomination and Remuneration Committees.

 

As announced in May of last year, Charles Allen-Jones had indicated a wish to step down from the board and he has retired with immediate effect. He is replaced as Senior Independent Non-Executive Director and Chairman of the Governance Committee by Charles Gregson, who will cease to be a member of the Audit Committee. Stuart Bridges is also appointed a member of the Governance Committee.

 

Commenting on the board changes, Rod Kent, Chairman of Caledonia, said:

 

"I am delighted that David Stewart and Shonaid Jemmett-Page have agreed to join Caledonia as independent non-executive directors. They both bring a wealth of experience in international business and investment, particularly in Asia and emerging markets, which will be of considerable benefit to our board.

 

I would also like to thank Charles Allen-Jones for the enormous contribution that he has made to the Company over the past 13 years, particularly as Senior Independent Director. His wise counsel will be greatly missed and we wish him well in his retirement."

 

 

 

Enquiries

 

Caledonia Investments plc

Rod Kent (Chairman)

Tel: +44 20 7802 8080

 

Tulchan Communications

Peter Hewer

Tel: +44 20 7353 4200

 

18 March 2015

 

There are no details relating to David Stewart or Shonaid Jemmett-Page which require disclosure under Listing Rule 9.6.13 (2) to (6).

 

In accordance with section 430 (2B) of the Companies Act 2006, Caledonia confirms that, other than fees payable to him up to the date of his retirement, no remuneration or payment has been or will be made in connection with Charles Allen-Jones ceasing to be a director of the Company.

 

 

END

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAQDLFFEXFLBBB
Date   Source Headline
6th Jun 202310:44 amRNSNet Asset Value(s)
1st Jun 20233:23 pmRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSDirectorate Change
23rd May 20237:00 amRNSFinal Results
9th May 20232:16 pmRNSNet Asset Value(s)
20th Apr 20239:40 amRNSAcquisition
12th Apr 202310:42 amRNSResponse to press speculation
11th Apr 20237:00 amRNSUnaudited net asset value and portfolio update
28th Mar 20231:50 pmRNSDirectorate Change
22nd Mar 20235:04 pmRNSDirector/PDMR Shareholding
14th Mar 20235:35 pmRNSDirector/PDMR Shareholding
6th Mar 20232:18 pmRNSNet Asset Value(s)
6th Feb 202311:47 amRNSNet Asset Value(s)
9th Jan 20237:00 amRNSUnaudited net asset value and portfolio update
7th Dec 20229:22 amRNSNet Asset Value(s)
22nd Nov 20227:00 amRNSDirectorate Change
22nd Nov 20227:00 amRNSHalf-year Report
7th Nov 202210:49 amRNSNet Asset Value(s)
7th Oct 20227:00 amRNSUnaudited net asset value and portfolio update
30th Sep 20224:21 pmRNSDirector/PDMR Shareholding
23rd Sep 20222:51 pmRNSDirector/PDMR Shareholding
6th Sep 202210:17 amRNSNet Asset Value(s)
23rd Aug 20225:21 pmRNSDirector/PDMR Shareholding
15th Aug 20222:21 pmRNSDirector Declaration
4th Aug 202212:41 pmRNSNet Asset Value(s)
27th Jul 20224:47 pmRNSResult of AGM
19th Jul 20224:59 pmRNSDirector Declaration
7th Jul 20227:00 amRNSUnaudited net asset value and portfolio update
23rd Jun 20224:00 pmRNSAnnual Financial Report
20th Jun 202212:20 pmRNSDirector/PDMR Shareholding
20th Jun 202212:20 pmRNSDirector/PDMR Shareholding
16th Jun 20224:32 pmRNSDirector/PDMR Shareholding
14th Jun 20221:51 pmRNSDirector/PDMR Shareholding
8th Jun 20229:36 amRNSNet Asset Value(s)
6th Jun 20223:33 pmRNSDirector/PDMR Shareholding
31st May 20224:50 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSFinal Results
6th May 20229:02 amRNSNet Asset Value(s)
7th Apr 20227:00 amRNSUnaudited net asset value and portfolio update
4th Apr 202210:10 amRNSDirectorate Change
25th Mar 20224:47 pmRNSDirector/PDMR Shareholding
21st Mar 20223:56 pmRNSDirector/PDMR Shareholding
16th Mar 20222:05 pmRNSDirector/PDMR Shareholding
7th Mar 20227:00 amRNSDirectorate Change
7th Mar 20227:00 amRNSNet Asset Value(s)
28th Feb 20224:59 pmRNSTotal Voting Rights
4th Feb 20224:56 pmRNSTransaction in Own Shares
4th Feb 20229:52 amRNSNet Asset Value(s)
31st Jan 20225:23 pmRNSTotal Voting Rights
28th Jan 20225:25 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.